Cloud-based platform provides real-time data insights for clinical trials
eClinical Insights, a leading-edge provider of cloud-based clinical trials software, announced today the launch of its eClinical Intelligence Platform. Built upon a first-in-class eClinical data hub that acquires and integrates data from any clinical system, and powered by a business analytics engine, the eClinical Insights platform delivers real-time clinical trial intelligence and workflow capabilities through a suite of cloud-based applications designed to help pharmaceutical, biotech, medical device, and contract research organizations improve the performance of their clinical trials through real-time data sharing and collaboration.
“With the average clinical trial using of 5-7 different clinical systems, one of the critical business challenges the industry faces today is turning these siloes of data into operational intelligence," said Peg Regan, President & CEO of eClinical Insights. “Our platform automatically leverages these disparate data into actionable information, and delivers it through an integrated suite of role-based applications. By eliminating operational blind spots, our technology platform empowers clinical research professionals with the visibility they need to make rapid, data-driven decisions."
The platform's open architecture includes a library of out-of-the-box interfaces to leading EDC technologies, enabling customers to leverage their existing technology investments as integrated components of the eClinical Insights platform. Delivered through a Software-as-a-Service (SaaS) subscription model, the platform includes a suite of cloud-based trial management applications that are available on per study basis, and can be turned on and off as needed, on both new and ongoing trials.
"We took a small data approach to solving a big data problem, and focused solely on the use of clinical trials data to optimize trial execution and collaboration," said Regan. "With a team that has decades of experience in clinical trials management, and unparalleled experience integrating data from EDC, IVR, ePRO, CTMS, and Central Laboratory systems, we had a unique vantage point from which to solve this challenge. We leveraged this experience in the development of a technology platform that delivers instant visibility across the diverse ecosystem of systems, service providers, and stakeholders of today's clinical trials."
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.